Investor Relations

Stock Information

Symbol

NYSE MKT: VNRX

Price

Loading...

Change

Loading...

Shares Oustanding

26093123

MKT Cap

Loading...

Volume

Loading...

Company Overview

Volition is a multi-national company developing simple, easy to use blood-based cancer tests to accurately diagnose a range of cancers. The tests are based on the science of Nucleosomics which is the practice of identifying and measuring nucleosomes in the bloodstream - an indication that cancer is present.

Volition's goal is to make the tests as common and simple to use, for both patients and doctors, as existing diabetic and cholesterol blood tests. Volition's research and development activities are currently centred in Belgium as the company focuses on bringing its diagnostic products to market first in Europe, then in the US and ultimately, worldwide.

IR Contact Information

Investor Relations
VolitionRx
Scott Powell
T: (646) 650-1351
investorrelations@volitionrx.com

Edison Advisors
Tirth Patel
T: (646) 653-7035
tpatel@edisongroup.com

Edison Advisors
Rachel Carroll
T: +44 (0) 20 3077 5711
rcarroll@edisongroup.com

Transfer Agent
VStock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598
T: 212-828-8436
F: 646-536-3179
info@vstocktransfer.com
www.vstocktransfer.com

arrow-down arrow-left arrow-right arrow chevron-down circle-link--red circle-link close play plus